Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation

<div>IFN<i>α</i> subtype signature in gut-associated lymphoid tissue (GALT) and peripheral blood mononuclear cells (PBMCs) from treated HIV-1-positive patients before (T0) and after 6 months (T6) of probiotic supplementation. Pie chart represents the expression of each IFN<i>α</i> subtype. Data are expressed as percentage.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation 

Figure 2 | Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation 